bpc-157 clinical trial tendon Regeneration or Risk? A Narrative Review of for Musculoskeletal Healing Breaking down BPC-157 / TB500
Description
Sources: Clinical Nutrition ESPEN (2020)
Glia [Internet]
Gonciarz W, Balcerczak E, Brzeziski M et al (2025) Chitosanbased formulations for therapeutic applications
Interestingly, there was no difference in MBP or MOG expression over time with treatment of rapamycin only, suggesting rapamycin does not affect myelination ex vivo
